Some aspects of drug eluting stents.
For the past few years, the cardiovascular stenting experienced an impressive growth. Beginning several years ago, however, it has come through with novel stent designing, manufacturing, and surface modification as well as drug delivery features. With the present dominance of drug eluting stent, this brief communication highlights a few of its characteristics to be useful in preventing restenosis.
Kathuria
Y P
YP
D000925:Anticoagulants / Q000008:administration & dosage; D023903:Coronary Restenosis / Q000517:prevention & control*; D004867:Equipment Design; D006083:Graft Occlusion, Vascular / Q000517:prevention & control*; D006801:Humans; D020136:Hydrogel, Polyethylene Glycol Dimethacrylate; D007166:Immunosuppressive Agents / Q000008:administration & dosage; D015607:Stents
D000925:Anticoagulants; D007166:Immunosuppressive Agents; D020136:Hydrogel, Polyethylene Glycol Dimethacrylate